BioSpace News Archive

Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the second quarter ended December 31, 2020 . Second Quarter FY2021 Snapshot Second quarter organic revenue increased by 19% (21% reported) to $224.3 million and 15% (16% reported) in the first half of fiscal 2021 to $428.5 million .

Karuna Therapeutics, Inc. (NASDAQ:KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that senior management will participate in a fireside chat at the 10 th Annual SVB Leerink Global Healthcare Conference on Thursday, February 25, 2021 at 9:20 a.m. EST. A live webcast of the presentation will b

Leading American nanomaterial and quantum dot producer and technology company, Quantum Materials Corp (OTCQB: QTMM) today announced an equity investment from California-based private equity firm, Pasaca Capital, Inc. of $15 million and under terms of the distribution agreement formed between the two companies, Q

Revitope Oncology, Inc., a biotechnology company advancing a new class of precision cancer immunotherapies, today announced the appointment of biotechnology pioneer Louis Lange , M.D., Ph.D., to its Board of Directors.

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that it will report its fourth quarter and full year 2020 financial results on Tuesday, February 9, 2021.

The retinal gene therapy market is estimated to expand at an exponential growth rate. For the use of gene therapy, retina is considered a highly desirable target as it an irreplaceable part of a body.

COVID-19 has been dominating the news headlines across the globe. This new global pandemic is caused by a new strand of coronavirus.

Hyperinflation system is a medical devices used for breathing assistance. Hyperinflation of lung is generally used for secretion removal and to improve lung compliance.

Next Generation Sequencing is utilized to execute different applications, for instance, biomarker revelation, oncology thinks about, customized solution, rural and creature research, and others.

Inmagene Biopharmaceuticals, a leading biotech company focused on immunology-related therapeutic areas, announced the launch of its wholly-owned subsidiary in San Diego.